<DOC>
	<DOCNO>NCT02403128</DOCNO>
	<brief_summary>Phase 1 , non-randomized , open label , noncomparative trial study effect intravitreal injection aflibercept eye symptomatic macular edema retinal artery macroaneurysms .</brief_summary>
	<brief_title>Intravitreal Aflibercept Injection Symptomatic Macular Edema From Retinal Artery Macroaneurysms</brief_title>
	<detailed_description>Baseline evaluation consist measurement best-corrected ETDRS visual acuity , complete eye exam , include IOP measurement , color photo intravenous fluorescein angiography , spectral domain OCT vitals . Patients meet eligibility criterion treat intravitreal injection 2.0 mg aflibercept usual aseptic precaution . Follow visit Day 7 , 30 , 60 , 90 , 120 , 150 180 . At follow-up visit , best-corrected ETDRS visual acuity , IOP measurement central foveal thickness ( CFT ) SDOCT obtain . Color photo IVFA perform month 3 6 visit . Retreatment shall perform sooner two month previous injection one follow criterion 1 . CFT &gt; 310 micron 2 . Intraretinal subretinal fluid SDOCT 3 . Increase CFT 50 micron low value observe intravitreal aflibercept injection 4 . Decrease vision 5 letter frpm previous visit associate OCT evidence macular edema . 5 . Appearance new hemorrhage color photograph . Final follow-up six month . Data collect include , change ETDRS visual acuity baseline , change CFT , number injection , number eye completely dry SDOCT , number eye thrombose RAM IVFA .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>1 . Symptomatic macular edema cause RAM one eye . If eye involve , eye bad central foveal thickness enrol study . 2 . CFT 310 micron spectral domain OCT lipid center fovea 3 . Bestcorrected visual acuity 73 24 letter . 4 . Willing able comply clinic visit studyrelated procedure . 5 . Willing provide inform consent 1 . Media opacity 2. preretinal fibrosis , retinal detachment , vitreomacular traction 3 . Infectious keratitis , conjunctivitis , blepharitis scleritis 4 . Any ocular surgery precede 3 month . 5. aphakia uncontrolled glaucoma 6. subfoveal hemorrhage 7 . History systemic intravitreal antiVEGF injection , intravitreal steroid injection implant , laser treatment RAM within six month 8 . Any ocular disease responsible decrease vision . 9 . Concomitant ocular disease cause increase foveal thickness 10 . Ocular inflammation cause 11 . Recent ( &lt; 3 month ) history thromboembolic event 12 . Pregnant breast feed woman . 13 . Sexually active men woman child bear potential unwilling practice adequate contraception study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>362.17</keyword>
</DOC>